462 related articles for article (PubMed ID: 17202334)
1. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
[TBL] [Abstract][Full Text] [Related]
2. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.
Tan JE; Wong SC; Gan SK; Xu S; Lam KP
J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of B cell linker protein enhances B cell signaling defects in mice expressing a limiting dosage of Bruton's tyrosine kinase.
Whyburn LR; Halcomb KE; Contreras CM; Pappu R; Witte ON; Chan AC; Satterthwaite AB
Int Immunol; 2003 Mar; 15(3):383-92. PubMed ID: 12618482
[TBL] [Abstract][Full Text] [Related]
5. Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution.
Hinman RM; Nichols WA; Diaz TM; Gallardo TD; Castrillon DH; Satterthwaite AB
Int Immunol; 2009 Jul; 21(7):831-42. PubMed ID: 19502585
[TBL] [Abstract][Full Text] [Related]
6. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
[TBL] [Abstract][Full Text] [Related]
7. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
Craxton A; Jiang A; Kurosaki T; Clark EA
J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
9. The autoinhibitory C-terminal SH2 domain of phospholipase C-γ2 stabilizes B cell receptor signalosome assembly.
Wang J; Sohn H; Sun G; Milner JD; Pierce SK
Sci Signal; 2014 Sep; 7(343):ra89. PubMed ID: 25227611
[TBL] [Abstract][Full Text] [Related]
10. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
Szydlowski M; Kiliszek P; Sewastianik T; Jablonska E; Bialopiotrowicz E; Gorniak P; Polak A; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Malenda A; Lech-Maranda E; Warzocha K; Juszczynski P
Blood; 2016 Feb; 127(6):739-48. PubMed ID: 26585955
[TBL] [Abstract][Full Text] [Related]
11. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.
Yasuda T; Tezuka T; Maeda A; Inazu T; Yamanashi Y; Gu H; Kurosaki T; Yamamoto T
J Exp Med; 2002 Jul; 196(1):51-63. PubMed ID: 12093870
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
Kim SJ; Winter K; Nian C; Tsuneoka M; Koda Y; McIntosh CH
J Biol Chem; 2005 Jun; 280(23):22297-307. PubMed ID: 15817464
[TBL] [Abstract][Full Text] [Related]
13. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
[TBL] [Abstract][Full Text] [Related]
14. Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling.
Watanabe D; Hashimoto S; Ishiai M; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
J Biol Chem; 2001 Oct; 276(42):38595-601. PubMed ID: 11507089
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
Bogusz AM; Baxter RH; Currie T; Sinha P; Sohani AR; Kutok JL; Rodig SJ
Clin Cancer Res; 2012 Nov; 18(22):6122-35. PubMed ID: 22966017
[TBL] [Abstract][Full Text] [Related]
16. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
Moyo TK; Wilson CS; Moore DJ; Eischen CM
Oncogene; 2017 Aug; 36(32):4653-4661. PubMed ID: 28368423
[TBL] [Abstract][Full Text] [Related]
17. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappaB signaling pathway in B lymphocytes.
Petro JB; Khan WN
J Biol Chem; 2001 Jan; 276(3):1715-9. PubMed ID: 11042193
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
20. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.
Hashimoto S; Iwamatsu A; Ishiai M; Okawa K; Yamadori T; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
Blood; 1999 Oct; 94(7):2357-64. PubMed ID: 10498607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
